Ysopia Bioscience Is A French Clinical Stage Biotechnology Company Founded In 2010The Company Specializes In Developing Gut Microbiome Based Therapies Aimed At Addressing Chronic Diseases With Significant Unmet Medical Needsformerly Known As Lnc Therapeuticsysopia Focuses On Creating Biotherapies Derived From Single Strain Keystone Bacteria Ysopia Operates As A Research Driven Firmcollaborating With Global Scientific Institutions And Academic Experts To Enhance Its Development Pipelineits Notable Programs Include Yso1Which Shows Strong Preclinical Efficacy In Metabolic And Inflammatory Conditionsand Xla1Which Successfully Completed Phase 1 Clinical Trials In July 2021Confirming Its Safety And Early Biological Activitythe Company Targets Conditions Such As Crohnae S Diseasemood Disordersand Cancer Through Microbiome Modulationfollowing An Acquisition In June 2023Ysopia Continues To Concentrate On Its Core Clinical Programs While Its Health And Wellness Strain Portfolio Is Managed By Verb Biotics
No conferences found for this company.
| Company Name | Ysopia Bioscience |
| Country |
France
|
| Address | N/A |
| Telephone | N/A |
| N/A |
